Jennewein Biotechnologie and Pfizer Nutrition collaborate in human milk components
RHEINBREITBACH, Germany, August 29, 2011/PRNewswire /-
• license agreement gives rights to Pfizer Nutrition for innovative human milk components and biological sources
Jennewein Biotechnologie today announced that the company has signed a license agreement with Pfizer Nutrition to develop and commercialize two human oligosaccharides of milk (HMOs).
The human milk oligosaccharides represent a prominent component of the milk of the mother, in addition to providing short and long term benefits for children from birth onwards. Scientific research has shown that the HMOs can reduce significantly the risk of infection of children during their time of lactation. In addition, these compounds are known to influence the colonization of beneficial bacteria and support healthy immune development.
The Association will focus on allowing the functional and immunological benefits from the HMOs to be available in the face of the children that are fed with formulas for children. Human milk, the gold standard ” thanks to its special composition of lipids, proteins and HMOs, is the best nutrition for children.
An experience close to a century as pioneers in nutritional science for children, we are improving steadily to more closely replicate the composition and functional benefits of breast milk, and this partnership really helps to achieve this objective ”, stated John Troup, PhD and Vice President of research and overall development of Pfizer Nutrition.
Dr. Stefan Jennewein, managing director and co-founder of Jennewein Biotechnologie, stressed: complex oligosaccharides in general and the HMOs in particular have shown great potential for use in human nutrition. Cooperation between Pfizer Nutrition and Jennewein Biotechnologie will accelerate the development in this field to meet the specific additional skills ”.
Jennewein plans to also focus on nutrition for adults, apart from in the formulas for children, and in the marketing of the HMOs to bring the benefits of this natural product to a broader group of consumers.
About Jennewein Biotechnologie
Jennewein Biotechnologie GmbH, founded in 2005 in Rheinbreitbach (Germany), is a scientific company based in the field of industrial biotechnology. The company focuses its activities on the development of innovative production processes for rare and complex Monosaccharides and oligosaccharides. Jennewein NRC aims to provide sugar with scientifically proven health benefits and make them available for large groups of consumption.
About Pfizer Nutrition
Pfizer Nutrition, formerly Wyeth Nutrition, is part of Pfizer Inc. Pfizer Nutrition supports the goal of the company to improve the health and well-being in each of the stages of life, providing depth and breadth to consumers and scientific vision to new people and new markets around the world. Pfizer Nutrition brings together nearly a century of experience in which the company has provided clinical rigor, scientific research, global manufacturing and product safety standards to boost scientific outstanding solutions that offer confidence to parents, help children grow and support your healthy future. We develop nutritious products with premium quality which have been designed in a scientific way to meet the needs of young people and children, as well as pregnant mothers and lactation phase.
